Sonoma Pharmaceuticals Inc (SNOA) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.28 (+1.59%), Market cap $0.00B, 52-week low–high $1.04 ~ $5.35.
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn
Financial statements, price targets, institutional (13F) holdings and related news for Sonoma Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Sonoma Pharmaceuticals Inc trades at $1.28 (+1.59%). Real-time quotes and charts are available on BlackAll Trade.
Sonoma Pharmaceuticals Inc has a market cap of about $0.00B.
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions